Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Castration-resistant, CYP17 Inhibitor-naïve Prostate Cancer: Results from Extended Follow-up of the ARADES Trial
- Resource Type
- Article
- Source
- In
European Urology Focus December 2017 3(6):606-614 - Subject
- Language
- ISSN
- 2405-4569